Identification of the circRNA–miRNA–mRNA network for treating methamphetamine‐induced relapse and behavioral sensitization with cannabidiol

Liu Liu,Chan Wang,Haowei Wang,Lin Miao,Tong Xie,Yunqing Tian,Xiaodong Li,Yizhen Huang,Xiaofeng Zeng,Bofeng Zhu
DOI: https://doi.org/10.1111/cns.14737
2024-05-05
CNS Neuroscience & Therapeutics
Abstract:Cannabidiol (CBD) administration alleviates methamphetamine (METH)‐induced conditioned place preference (CPP) reinstatement and behavioral sensitization in mice. The circMeis2‐miR‐183‐5p‐Kcnj5 network in the nucleus accumbens is involved in this process. This study established the first competing endogenous RNAs network to reveal the potential mechanism of CBD in treating METH‐induced CPP reinstatement and behavioral sensitization, advancing the application of CBD in treating METH use disorders. Aims This study aims to investigate the pharmacological effects and the underlying mechanism of cannabidiol (CBD) on methamphetamine (METH)‐induced relapse and behavioral sensitization in male mice. Methods The conditioned place preference (CPP) test with a biased paradigm and open‐field test were used to assess the effects of CBD on METH‐induced relapse and behavioral sensitization in male mice. RNA sequencing and bioinformatics analysis was employed to identify differential expressed (DE) circRNAs, miRNAs, and mRNAs in the nucleus accumbens (NAc) of mice, and the interaction among them was predicted using competing endogenous RNAs (ceRNAs) network analysis. Results Chronic administration of CBD (40 mg/kg) during the METH withdrawal phase alleviated METH (2 mg/kg)‐induced CPP reinstatement and behavioral sensitization in mice, as well as mood and cognitive impairments following behavioral sensitization. Furthermore, 42 DEcircRNAs, 11 DEmiRNAs, and 40 DEmRNAs were identified in the NAc of mice. The circMeis2‐miR‐183‐5p‐Kcnj5 network in the NAc of mice is involved in the effects of CBD on METH‐induced CPP reinstatement and behavioral sensitization. Conclusions This study constructed the ceRNAs network for the first time, revealing the potential mechanism of CBD in treating METH‐induced CPP reinstatement and behavioral sensitization, thus advancing the application of CBD in METH use disorders.
pharmacology & pharmacy,neurosciences
What problem does this paper attempt to address?